Clinical Trial Update: Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative romiplostim to treat thrombocytopenia in patients undergoing cardiac surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)

Snippet

Sponsor: Nantes University Hospital | Conditions: Chirurgical Intervention, Thrombocytopaenia | Phase 2 | Status: RECRUITING